Maternal vitamin A deficiency during pregnancy affects vascularized islet development

J Nutr Biochem. 2016 Oct:36:51-59. doi: 10.1016/j.jnutbio.2016.07.010. Epub 2016 Aug 4.

Abstract

Vitamin A deficiency is known to affect 20 million pregnant women worldwide. However, the prenatal effects of maternal vitamin A deficiency on pancreas development have not been clearly determined. The present study examined how maternal vitamin A deficiency affects fetal islet development. Vitamin A-deficient mice were generated by feeding female mice with a chemically defined diet lacking vitamin A prior to mating as well as during pregnancy. We found that maternal vitamin A deficiency during pregnancy affected fetal pancreas development. Although the exocrine differentiation appeared normal, development of islet tissue was impaired. In the pancreas of neonatal mice, only a few endocrine cell clusters were formed, and these cell clusters lacked capillary endothelial cells. To further determine how vitamin A metabolites, such as retinoic acid, regulate vascularized islet development, ex vivo culture of embryonic pancreas either in the presence of 4-diethylaminobenzaldehyde (DEAB; an inhibitor of retinaldehyde dehydrogenase), all-trans retinoic acid (atRA) or retinoic acid receptor agonist (E)-4-[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthylenyl)-1-propenyl] benzoic acid (TTNPB) was carried out. We found that the addition of DEAB blocked vascularization and suppressed β-cell differentiation. Conversely, atRA or TTNPB promoted β-cell differentiation accompanied by enhanced expression of vascular basement component, laminin. We further demonstrated that atRA regulated vascularization via upregulating vascular endothelial growth factor-A (VEGF-A) secretion in embryonic pancreas and treatment with VEGF-A was able to partially rescue vascularization and β-cell differentiation in DEAB-treated embryonic pancreas cultures. The findings explain why maternal vitamin A deficiency affects fetal islet development and support an essential role of retinoid signaling in regulating vascularized islet development.

Keywords: All-trans retinoic acid; Islet vascularization; Laminin; Vascular endothelial growth factor; Vitamin A deficiency.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Benzaldehydes / pharmacology
  • Benzoates / pharmacology
  • Cell Differentiation / drug effects
  • Embryo, Mammalian / cytology
  • Embryo, Mammalian / pathology
  • Enzyme Inhibitors / pharmacology
  • Female
  • Fetal Development* / drug effects
  • Insulin-Secreting Cells / drug effects
  • Insulin-Secreting Cells / metabolism
  • Insulin-Secreting Cells / pathology*
  • Islets of Langerhans / blood supply
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism
  • Islets of Langerhans / pathology*
  • Maternal Nutritional Physiological Phenomena*
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neovascularization, Physiologic* / drug effects
  • Pregnancy
  • Random Allocation
  • Receptors, Retinoic Acid / agonists
  • Receptors, Retinoic Acid / antagonists & inhibitors
  • Receptors, Retinoic Acid / metabolism
  • Retinal Dehydrogenase / antagonists & inhibitors
  • Retinal Dehydrogenase / metabolism
  • Retinoids / pharmacology
  • Tissue Culture Techniques
  • Tretinoin / metabolism
  • Vitamin A Deficiency / metabolism
  • Vitamin A Deficiency / pathology*

Substances

  • Benzaldehydes
  • Benzoates
  • Enzyme Inhibitors
  • Receptors, Retinoic Acid
  • Retinoids
  • 4-(diethylamino)benzaldehyde
  • Tretinoin
  • 4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid
  • Retinal Dehydrogenase